Absci (ABSI) Short Interest


ABSI Absci Corp ABSI
48 GF Score
Price $10.89
GF Value $0.94
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Absci Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ABSI vs CRVS, JBIO, SVRA: Short Interest Comparison

For the Biotechnology subindustry, Absci's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Absci Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Absci's Short Interest distribution charts can be found below:

* The bar in red indicates where Absci's Short Interest falls into.


ABSI
48GF Score
Absci Corp ABSI
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Absci (ABSI) Overvalued in 2026?

Based on GuruFocus' analysis, Absci stock appears to be overvalued. The current stock price of $10.89 is trading 1058.5% above its estimated GF Value™ of $0.94. GuruFocus considers Absci to be Significantly Overvalued.

Key valuation signals for ABSI:

  • Short Interest:
  • GF Value™: $0.94 vs. price of $10.89 (1058.5% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the ABSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Absci Business Description

Address 18105 SE Mill Plain Boulevard, Vancouver, WA, USA, 98683
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
48GF Score

Get the complete analysis for ABSI

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.89
Price
$0.94
GF Value